A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma.
In: Cancer Investigation, Jg. 42 (2024-03-01), Heft 3, S. 226-242
academicJournal
Zugriff:
Chronic inflammation promotes the development of pancreatic ductal adenocarcinoma (PDAC) and PDAC-related inflammatory tumor microenvironment facilitates tumor growth and metastasis. Thus, we aimed to study the association between inflammatory response and prognosis in patients with PDAC. We conducted the whole transcriptomic sequencing using tissue samples collected from patients diagnosed with PDAC (n = 106) recruited from Shandong Cancer Hospital. We first constructed a prognostic signature using 15 inflammation-related genes in The Cancer Genome Atlas (TCGA) cohort (n = 177) and further validated it in an independent International Cancer Genome Consortium (ICGC) cohort (n = 90) and our in-house cohort. PDAC patients with a higher risk score had poorer overall survival (OS) (P < 0.001; HR, 3.02; 95% CI, 1.94-4.70). The association between the prognostic signature and OS remained significant in the multivariable Cox regression adjusting for age, sex, alcohol exposure, diabetes, and stage (P < 0.001; HR, 2.91; 95% CI, 1.73-4.89). This gene signature also robustly predicted prognosis in the ICGC cohort (P = 0.01; HR, 1.94; 95% CI, 1.14-3.30) and our cohort (P < 0.001; HR, 2.40; 95% CI, 1.45-3.97). Immune subtype C3 (inflammatory) was enriched and CD8+ T cells were higher in patients with a lower risk score (P < 0.05). Furthermore, PDAC patients with higher risk scores were more sensitive to chemotherapy, immunotherapy, and PARP inhibitors (P < 0.05). In sum, we identified a novel gene signature that was associated with inflammatory response for risk stratification, prognosis prediction, and therapy guidance in PDAC patients. Future studies are warranted to validate the clinical utility of the signature. [ABSTRACT FROM AUTHOR]
Titel: |
A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma.
|
---|---|
Autor/in / Beteiligte Person: | Sun, Xiaofeng ; Song, Hao ; Sun, Xiaoran ; Liao, Chunhua ; Wang, Guoqiang ; Xu, Yu ; Li, Leo ; Han, Yusheng ; Xu, Chunwei ; Wang, Wenxian ; Cai, Shangli ; Liang, Hua ; Yu, Hao |
Zeitschrift: | Cancer Investigation, Jg. 42 (2024-03-01), Heft 3, S. 226-242 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 0735-7907 (print) |
DOI: | 10.1080/07357907.2024.2340577 |
Schlagwort: |
|
Sonstiges: |
|